Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate in Juvenile Osteoporosis
NCT00259857Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Oct 2003
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in juvenile osteoporosis comparing Alendronate First with Placebo First (2 arms). Primary endpoint: Bone Mineral Density of Spine at 24 months. Started Oct 2003; status: completed.
02
Drugs
alendronate
03
Conditions
juvenile osteoporosis
Beyond the preview
Go deeper on NCT00259857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259857.